Ocular Therapeutix (OCUL) Competitor Comparison
We are evaluating the key criteria listed to compare Ocular Therapeutix (OCUL) against its competitors in the Biotechnology industry.
Market Capitalization
120 / 368Gross Profits
156 / 278Total Revenue
112 / 300EBITDA
176 / 337Free Cashflow
201 / 352Quick Ratio
228 / 357Earnings per Share
138 / 359Dividend yield
0 / 6Total Cash
207 / 358Performance 3 years
59 / 368Performance 5 years
41 / 368Performance 10 years
129 / 368Linearity 3 years
249 / 368Linearity 5 years
315 / 368Linearity 10 years
82 / 368Total Rank
213 / 368Dividend Rank
223 / 368Valuation Rank
221 / 368Piotroski Rank
197 / 368Muliplier Rank
167 / 368Free Cashflow - OCUL ranking 201 / 352
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.